G
Giovanni B. Frisoni
Researcher at University of Geneva
Publications - 956
Citations - 55940
Giovanni B. Frisoni is an academic researcher from University of Geneva. The author has contributed to research in topics: Dementia & Medicine. The author has an hindex of 101, co-authored 871 publications receiving 46199 citations. Previous affiliations of Giovanni B. Frisoni include Geneva College & University of Rome Tor Vergata.
Papers
More filters
Journal ArticleDOI
Reduction of Abeta amyloid pathology in APPPS1 transgenic mice in the absence of gut microbiota.
Taoufiq Harach,Nittaya Marungruang,N. Duthilleul,V. Cheatham,K. D. Mc Coy,Giovanni B. Frisoni,Jonas J. Neher,Frida Fåk,Mathias Jucker,Theo Lasser,Tristan Bolmont +10 more
TL;DR: This work sequenced bacterial 16S rRNA from fecal samples of Aβ precursor protein (APP) transgenic mouse model and found a remarkable shift in the gut microbiota as compared to non-transgenic wild-type mice, indicating a microbial involvement in the development of Abeta amyloid pathology and suggesting that microbiota may contribute to the developed neurodegenerative diseases.
Journal ArticleDOI
Resting state fMRI in Alzheimer's disease: beyond the default mode network.
Federica Agosta,Michela Pievani,Cristina Geroldi,Massimiliano Copetti,Giovanni B. Frisoni,Massimo Filippi +5 more
TL;DR: The results suggest that AD is associated with an alteration of large-scale functional brain networks, which extends well beyond the DMN, which may be paralleled, in an attempt to maintain cognitive efficiency, by an increased prefrontal connectivity.
Journal ArticleDOI
Distinct patterns of brain activity in young carriers of the APOE e4 allele
Nicola Filippini,Bradley J. MacIntosh,M. Hough,Guy M. Goodwin,Giovanni B. Frisoni,Klaus P. Ebmeier,Stephen M. Smith,Paul M. Matthews,Christian F. Beckmann,Clare E. Mackay +9 more
Journal ArticleDOI
Brain atrophy in Alzheimer's Disease and aging.
Lorenzo Pini,Michela Pievani,Martina Bocchetta,Daniele Altomare,Paolo Bosco,Enrica Cavedo,Samantha Galluzzi,Moira Marizzoni,Giovanni B. Frisoni +8 more
TL;DR: A comprehensive overview of the main findings in AD and normal aging over the past twenty years, focusing on the patterns of gray and white matter changes assessed in vivo using MRI.
Journal ArticleDOI
Presymptomatic cognitive and neuroanatomical changes in genetic frontotemporal dementia in the Genetic Frontotemporal dementia Initiative (GENFI) study: a cross-sectional analysis
Jonathan D. Rohrer,Jennifer M. Nicholas,Jennifer M. Nicholas,David M. Cash,John C. van Swieten,Elise G.P. Dopper,Lize C. Jiskoot,Rick van Minkelen,Serge A.R.B. Rombouts,M. Jorge Cardoso,Shona Clegg,Miklos Espak,Simon Mead,David L. Thomas,Enrico De Vita,Mario Masellis,Sandra E. Black,Morris Freedman,Ron Keren,Bradley J. MacIntosh,Ekaterina Rogaeva,David F. Tang-Wai,Maria Carmela Tartaglia,Robert Laforce,Fabrizio Tagliavini,Pietro Tiraboschi,Veronica Redaelli,Sara Prioni,Marina Grisoli,Barbara Borroni,Alessandro Padovani,Daniela Galimberti,Elio Scarpini,Andrea Arighi,Giorgio G. Fumagalli,James B. Rowe,Ian Coyle-Gilchrist,Caroline Graff,Caroline Graff,Marie Fallström,Vesna Jelic,Vesna Jelic,Anne Kinhult Ståhlbom,Anne Kinhult Ståhlbom,Christin Andersson,Christin Andersson,Håkan Thonberg,Håkan Thonberg,Lena Lilius,Giovanni B. Frisoni,Giuliano Binetti,Michela Pievani,Martina Bocchetta,Luisa Benussi,Roberta Ghidoni,Elizabeth Finger,Sandro Sorbi,Benedetta Nacmias,Gemma Lombardi,Cristina Polito,Jason D. Warren,Sebastien Ourselin,Nick C. Fox,Martin N. Rossor +63 more
TL;DR: Structural imaging and cognitive changes can be identified 5-10 years before expected onset of symptoms in asymptomatic adults at risk of genetic frontotemporal dementia, which could help to define biomarkers that can stage presymPTomatic disease and track disease progression.